Long‐term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception
- 3 April 2003
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 460 (1), 38-55
- https://doi.org/10.1002/cne.10633
Abstract
Here we examine whether a permanent reduction in the noradrenergic (NA) innervation of the spinal cord leads to a chronic decreased nociceptive threshold. NA denervation of rats was achieved by intrathecal injection of dopamine beta-hydroxylase antibodies conjugated to the toxin saporin. A subset of animals also underwent unilateral L5 spinal nerve ligature to induce sustained neuropathic pain behavior. NA fibers and terminals were lost throughout the spinal cord 2 weeks after toxin application and were still absent 12 months later, indicating that regeneration did not occur. There was also a widespread loss of NA terminals in the cerebral cortex, whereas innervation of the hypothalamus and amygdala were close to normal and NA innervation of the brainstem was moderately reduced. There was extensive loss of NA cells in the locus coeruleus and A5 and A7 cell groups. Dopaminergic and serotoninergic innervation was normal. Intracerebroventricular injection of the toxin resulted in additional NA reduction in the hypothalamus, amygdala, and A1 and A2 cell groups. Long-term removal of NA afferents did not affect nociceptive thresholds. Neuropathic animals showed greater mechanical hyperalgesia in the affected hindpaw only during the first 60 days after toxin. Rats lacking NA spinal afferents were less responsive to the antinociceptive effects of morphine, especially in the neuropathic hindpaw, and did not display opioid-dependent stress analgesia. Finally, in the spinal cord of toxin-treated rats, immunoreactivity for substance P was decreased, whereas that of its receptor (NK1) was increased. These animals exhibited antinociception to a low dose of an NK1 receptor antagonist. Our results suggest that NA contributes only modestly to determining the nociceptive threshold and that its antinociceptive effects are closely linked to opioidergic and tachykinergic neurotransmission. J. Comp. Neurol. 460:38–55, 2003.Keywords
This publication has 83 references indexed in Scilit:
- The Mechanical Antihyperalgesic Effect of Intrathecally Administered MPV-2426, a Novel α2-Adrenoceptor Agonist, in a Rat Model of Postoperative PainAnesthesiology, 2000
- Allodynia and hyperalgesia evoked by sciatic mononeuropathy in NK1 receptor knockout miceNeuroReport, 2000
- Intrathecal, but Not Intravenous, Clonidine Reduces Experimental Thermal or Capsaicin-Induced Pain and Hyperalgesia in Normal VolunteersAnesthesia & Analgesia, 1998
- The formalin test in rat: validation of an automated systemPain, 1996
- Noxious peripheral stimulation produces antinociception mediated via substance P and opioid mechanisms in the rat tail-flick testBrain Research, 1995
- The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociceptionBrain Research, 1993
- Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesiaBrain Research, 1987
- Limited involvement of central noradrenergic pathways in morphine-induced antinociceptionNeuropharmacology, 1984
- Effects of the noradrenaline neurotoxin DSP 4 on monoamine neurons and their transmitter turnover in rat CNSJournal of Neural Transmission, 1984
- Catecholamine metabolism in the patients with rheumatoid arthritis.The Tohoku Journal of Experimental Medicine, 1977